Vendors to participate in CMS Rx drug anti-fraud program
The Centers for Medicare and Medicaid Services has chosen eight vendors to to analyze data to reveal problems that may indicate fraud or abuse in the new prescription drug benefit.
The Centers for Medicare and Medicaid Services has selected eight Medicare Rx Integrity Contractors to uncover fraud, waste and abuse in the new Medicare prescription drug program that takes effect Jan. 1, 2006. Enrollment for the benefit begins Nov. 15.
The vendors chosen earlier this month will compete for task orders under the master contract to analyze data to reveal problems that may indicate fraud or abuse, and investigate potentially fraudulent activities related to enrollment, eligibility and distribution of the prescription drug benefit. They may also develop and refer cases to the appropriate law enforcement agency if needed.
The eight contractors are:
- Delmarva Foundation for Medical Care Inc. of Easton, Md.
- EDS Corp. of Plano, Texas
- IntegriGuard LLC of Omaha, Neb.
- Livanta LLC of Annapolis Junction, Md.
- Maximus Federal Services Inc. of Reston, Va.
- NDCHealth of Atlanta
- Perot Systems Government Services Inc. of Alexandria, Va. and
- Science Applications International Corp. of San Diego.
EDS gets task order
Mary Mosquera is a staff writer forsister publication,Government Computer News
NEXT STORY: DRC wins Navy financial systems work